Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Liabilities and Shareholders Equity (2016 - 2026)

Nutex Health (NUTX) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $957.3 million as the latest value for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 25.65% year-over-year to $957.3 million; the TTM value through Mar 2026 reached $3.7 billion, up 61.6%, while the annual FY2025 figure was $918.5 million, 40.16% up from the prior year.
  • Liabilities and Shareholders Equity hit $957.3 million in Q1 2026 for Nutex Health, up from $918.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $964.5 million in Q3 2025 and bottomed at $83.3 million in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $583.9 million, with a median of $438.5 million recorded in 2024.
  • Year-over-year, Liabilities and Shareholders Equity surged 1026.99% in 2022 and then tumbled 49.96% in 2023.
  • Nutex Health's Liabilities and Shareholders Equity stood at $431.8 million in 2022, then fell by 7.76% to $398.2 million in 2023, then soared by 64.55% to $655.3 million in 2024, then soared by 40.16% to $918.5 million in 2025, then increased by 4.22% to $957.3 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $957.3 million, $918.5 million, and $964.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.